Deeper Intubation Make Effects on Cervical Esophageal ESD
Recruiting now · Phase 4
Conditions studied: Carcinoma in Situ of Cervical Part of Esophagus
In brief
To compare the efficacy and safety of intratracheal deep intubation with traditional intubation in endoscopic submucosal dissection for early esophageal cancer in the cervical esophagus, and to follow up and assess their short-term clinical outcomes.
Key facts
- Study ID
- NCT06420258
- Run by
- Fujian Provincial Hospital
- People needed
- 40
- Starts
- 2022-10-01
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2024-05-17
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- The lesions mainly involve superficial esophageal squamous cell carcinoma or high-grade intraepithelial neoplasia (HGIN) in the cervical esophagus;
- There is no evidence of regional lymph node or distant metastasis on endoscopic ultrasound (EUS) or CT/MRI imaging;
- Participants have a thorough understanding of this study and voluntarily sign the informed consent form.
You may not qualify if…
- 1. Patients who have received radiotherapy or chemotherapy before endoscopic submucosal dissection surgery; 2. Patients with severe comorbidities who are not suitable for endoscopic submucosal dissection surgery.
Where it is running
- Fujian Provintial Hospital — Fuzhou, Fujian, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.